AHN-GOOK PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7,420 KRW | -0.80% |
|
-2.88% | -21.15% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 113,958 | 123,186 | 148,969 | 122,613 | 104,448 | 106,948 |
| Enterprise Value (EV) 1 | 79,288 | 72,802 | 119,504 | 95,344 | 86,011 | 89,181 |
| P/E ratio | 8.71 x | 48.6 x | -113 x | 31.1 x | 15.2 x | 82.9 x |
| Yield | 2.22% | 2.05% | 1.69% | 2.06% | 2.39% | 2.34% |
| Capitalization / Revenue | 0.61 x | 0.79 x | 1.04 x | 0.75 x | 0.51 x | 0.46 x |
| EV / Revenue | 0.43 x | 0.47 x | 0.83 x | 0.58 x | 0.42 x | 0.38 x |
| EV / EBITDA | 4.26 x | 11.6 x | 25.8 x | 27.9 x | 6.01 x | 8.84 x |
| EV / FCF | -15 x | 4.16 x | -9.75 x | -96.5 x | 49.7 x | 19.9 x |
| FCF Yield | -6.65% | 24.1% | -10.3% | -1.04% | 2.01% | 5.04% |
| Price to Book | 0.77 x | 0.83 x | 1.03 x | 0.8 x | 0.67 x | 0.7 x |
| Nbr of stocks (in thousands) | 11,511 | 11,459 | 11,459 | 11,459 | 11,365 | 11,365 |
| Reference price 2 | 9,900 | 10,750 | 13,000 | 10,700 | 9,190 | 9,410 |
| Announcement Date | 19-03-21 | 20-03-12 | 21-03-17 | 22-03-21 | 23-03-22 | 24-03-20 |
1KRW in Million2KRW
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 185,746 | 155,852 | 143,364 | 163,534 | 205,389 | 233,676 |
| EBITDA 1 | 18,629 | 6,272 | 4,634 | 3,423 | 14,311 | 10,084 |
| EBIT 1 | 15,366 | 2,418 | -49.1 | -1,084 | 9,381 | 5,061 |
| Operating Margin | 8.27% | 1.55% | -0.03% | -0.66% | 4.57% | 2.17% |
| Earnings before Tax (EBT) 1 | 16,366 | 2,176 | 778.1 | 3,805 | 7,375 | 4,267 |
| Net income 1 | 13,220 | 2,536 | -1,315 | 3,939 | 6,875 | 1,290 |
| Net margin | 7.12% | 1.63% | -0.92% | 2.41% | 3.35% | 0.55% |
| EPS 2 | 1,136 | 221.3 | -114.8 | 343.9 | 604.0 | 113.5 |
| Free Cash Flow 1 | -5,274 | 17,516 | -12,257 | -988.1 | 1,732 | 4,491 |
| FCF margin | -2.84% | 11.24% | -8.55% | -0.6% | 0.84% | 1.92% |
| FCF Conversion (EBITDA) | - | 279.29% | - | - | 12.1% | 44.54% |
| FCF Conversion (Net income) | - | 690.79% | - | - | 25.19% | 348.14% |
| Dividend per Share 2 | 220.0 | 220.0 | 220.0 | 220.0 | 220.0 | 220.0 |
| Announcement Date | 19-03-21 | 20-03-12 | 21-03-17 | 22-03-21 | 23-03-22 | 24-03-20 |
1KRW in Million2KRW
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 34,670 | 50,384 | 29,465 | 27,269 | 18,437 | 17,767 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | -5,274 | 17,516 | -12,257 | -988 | 1,732 | 4,491 |
| ROE (net income / shareholders' equity) | 9.26% | 1.45% | -0.95% | 2.52% | 4.47% | 0.65% |
| ROA (Net income/ Total Assets) | 4.56% | 0.7% | -0.01% | -0.32% | 2.64% | 1.37% |
| Assets 1 | 289,753 | 361,508 | 9,009,430 | -1,226,025 | 260,264 | 94,314 |
| Book Value Per Share 2 | 12,808 | 12,937 | 12,575 | 13,441 | 13,683 | 13,382 |
| Cash Flow per Share 2 | 1,874 | 1,985 | 1,114 | 1,196 | 1,610 | 2,551 |
| Capex 1 | 2,914 | 3,738 | 24,119 | 4,035 | 2,931 | 5,474 |
| Capex / Sales | 1.57% | 2.4% | 16.82% | 2.47% | 1.43% | 2.34% |
| Announcement Date | 19-03-21 | 20-03-12 | 21-03-17 | 22-03-21 | 23-03-22 | 24-03-20 |
1KRW in Million2KRW
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -21.15% | 60.86M | |
| +20.78% | 43.29B | |
| +27.64% | 22.38B | |
| +18.81% | 15.51B | |
| +18.68% | 14.52B | |
| +54.64% | 12.93B | |
| -0.05% | 6.79B | |
| -11.39% | 6.56B | |
| +17.73% | 5.87B | |
| -8.87% | 5.73B |
- Stock Market
- Equities
- A001540 Stock
- Financials Ahn-Gook Pharmaceutical Co., Ltd.
